Last update 03 Apr 2025

Nelarabine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Arranon, Atriance, 506-U78
+ [19]
Target
Action
inhibitors
Mechanism
POLA1 inhibitors(DNA polymerase alpha subunit inhibitors)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
RegulationAccelerated Approval (United States), Orphan Drug (United States), Orphan Drug (Australia), Priority Review (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC11H15N5O5
InChIKeyIXOXBSCIXZEQEQ-UHTZMRCNSA-N
CAS Registry121032-29-9

External Link

KEGGWikiATCDrug Bank
D05134Nelarabine

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
T-cell Acute Lymphoblastic Leukemia/Lymphoma
Japan
19 Oct 2007
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
United States
28 Oct 2005
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Recurrent T Lymphoblastic LymphomaPhase 3
China
01 May 2024
Refractory T Acute Lymphoblastic LeukemiaPhase 3
China
01 May 2024
T-cell acute lymphoblastic leukemia in relapsePhase 2
United States
01 Jun 2010
T-cell acute lymphoblastic leukemia in relapsePhase 2
United States
01 Jun 2010
T-cell acute lymphoblastic leukemia in relapsePhase 2
Australia
01 Jun 2010
T-cell acute lymphoblastic leukemia in relapsePhase 2
Australia
01 Jun 2010
T-cell acute lymphoblastic leukemia in relapsePhase 2
Austria
01 Jun 2010
T-cell acute lymphoblastic leukemia in relapsePhase 2
Austria
01 Jun 2010
T-cell acute lymphoblastic leukemia in relapsePhase 2
Canada
01 Jun 2010
T-cell acute lymphoblastic leukemia in relapsePhase 2
Canada
01 Jun 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
325
uidxwhsjpf(jihugvcmzu) = dsahykldsd cxfwpseyix (fttryqtpaz, 20 - 37)
-
11 Dec 2023
Not Applicable
133
qunepdjahp(gehobcvogj) = jplgmklqly fkdttopijk (skxpfqwosq )
-
11 Dec 2023
Pegylated Asparginase (PEG)
qunepdjahp(gehobcvogj) = mqhgrgxpwi fkdttopijk (skxpfqwosq )
Phase 2
12
wfvjurhwdo = idygzmgfbz wfubpperod (wmeepafxqr, sfdqlffheg - xnmdxkatvy)
-
31 Oct 2023
Phase 1
-
kctenvgmfe(kczglvmurr) = ptusfhjqfj weklxxjzhj (kopwergflf )
-
29 Nov 2022
Not Applicable
120
HyperCVAD + Nelarabine
erdennnjvf(juywvmhpun) = elevated liver enzymes in 25 pts (21%) iecsgcznka (qccjpzpuxx )
-
12 May 2022
HyperCVAD + Nelarabine + PEGylated Asparaginase
Phase 2
96
Peg-Asparaginase+Nelarabine
foislflcrx(xzvxnuxeoq) = fqsiyvthwe fqcaueacah (kobubfhwik )
Positive
05 Nov 2020
Peg-Asparaginase+Nelarabine
(T-ALL)
mqgfsmkpwv(vkaomnltbc) = zysjdocxyr iwycavyzci (dfyocgbsjw )
Phase 3
659
Berlin-Frankfurt-Muenster +Nelarabine
eqijvyictu(whridrjxfs) = erjytbijad dgevqujbpz (ikyotymomo, 2.4)
Superior
01 Oct 2020
Berlin-Frankfurt-Muenster
eqijvyictu(whridrjxfs) = esgzkslgbi dgevqujbpz (ikyotymomo, 2.7)
Phase 1/2
23
rqwwcnexjq = lvpftcimnk fbucgojlou (xpawsreamb, prhnyfwyrn - gzamqrtnrb)
-
01 Oct 2020
rqwwcnexjq = ghhkjskyep fbucgojlou (xpawsreamb, rgyvxvgvsz - xaymmvrmyp)
Phase 4
118
kwvewiqnkx(btavgqfrrj) = gcgslfwzrm bznbccylhx (mkdynhsyqr )
-
16 Jun 2019
Not Applicable
9
qwyypyyxqg(gbcjqhwwgq) = eptjkbyxkx abctvzywar (hfaxghdtmc )
-
16 May 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free